Key result
This review outlines the history, classification, genetic background, and gene therapy of cardiomyopathies, noting the modern inclusion of electrical dysfunctions without structural substrates.
This review summarizes the historical evolution, classification, and genetic basis of cardiomyopathies, including electrical disorders without structural substrates.
Cardiomyopathies are a heterogeneous group of diseases of the myocardium associated with dysfunction, with or without a structural substrate. They are frequently genetically determined. The dysfunction may be mechanical, both of the systole and diastole, or electrical, including arrhythmias or conduction disorders. Originally, only dilated, hypertrophic, restrictive-obliterative and arrhythmogenic dysfunctions were considered cardiomyopathies. Nowadays, since dysfunction can also be electric, disorders affected by electrical dysfunction without a structural substrate can be regarded as cardiomyopathies as well. This is the case of channellopathies and ryanodine receptors. This paper is a review of the history of cardiomyopathies, including the issues of their classification and nomination, genetic background and gene therapy.
No takes yet. Share an insight, caveat, or question.
Thiene et al. (2025) conducted a review in Cardiomyopathies. This review outlines the history, classification, genetic background, and gene therapy of cardiomyopathies, noting the modern inclusion of electrical dysfunctions without structural substrates.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: